No benefit found from continuing neuroleptic drugs in Alzheimer's patients

Results of a randomised trial published in PLoS Medicine show no benefit in cognitive or neuropsychiatric outcomes from continuing neuroleptic drugs in patients with Alzheimer’s disease.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news126256440.html">No benefit found from continuing neuroleptic drugs in Alzheimer's patients</a></p> <p>Results of a randomised trial published in <i>PLoS Medicine</i> show no benefit in cognitive or neuropsychiatric outcomes from continuing neuroleptic drugs in patients with Alzheimer’s disease.</p>